Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment.
Journal: Journal of neurodevelopmental disorders
Published: March 15, 2022
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX).
Journal: Journal of neurodevelopmental disorders
Published: March 11, 2022
Showing 1-2 of 2
Last Updated: 09/26/2026